The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial

Diabetes Research and Clinical Practice

Volumn 92, Issue 2, 2011, Pages 253-260

  de Oliveira, Andreia Madruga ^a   Rondó, Patrícia Helen Carvalho ^a   Luzia, Liania Alves ^a   D'Abronzo, Francisco Homero ^b   Illison, Vanessa Kristine ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Jundiaí Medical School   (Brazil)

Author keywords

Insulin resistance; Lipoic acid; Metabolic syndrome; Type 2 diabetes mellitus; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THIOCTIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALPHA-TOCOPHEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; THIOCTIC ACID;

EID: 79955872580     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.02.010     Document Type: Article

References (39)

1. World Health Organization Diabetes Programme; 2010. Available from [accessed 12 April 2010]. http://www.who.int/diabetes/en/.
2. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
3. Son S.M., Whalin M.K., Harrison D.G., Taylor W.R., Griendling K.K. Oxidative stress and diabetic vascular complications. Curr Diab Rep 2004, 4(4):247-252.
4. Gianturco V., Bellomo A., D'Ottavio E., Formosa V., Iori A., Mancinella M., et al. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?. Arch Gerontol Geriatr 2009, 49(Suppl. 1):129-133.
5. Packer L., Kraemer K., Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001, 17(10):888-895.
6. Blumenthal S.A. Inhibition of gluconeogenesis in rat liver by lipoic acid. Evidence for more than one site of action. Biochem J 1984, 219(3):773-780.
7. Ziegler D., Hanefeld M., Ruhnau K.J., Hasche H., Lobisch M., Schütte K., et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999, 22(8):1296-1301.
8. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997, 20(3):369-373.
9. Amom Z., Zakaria Z., Mohamed J., Azlan A., Bahari H., Taufik Hidayat Baharuldin M., et al. Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis. J Clin Biochem Nutr 2008, 43(2):88-94.
10. Zulkhairi A., Zaiton Z., Jamaluddin M., Sharida F., Mohd T.H., Hasnah B., et al. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit. Biomed Pharmacother 2008, 62(10):716-722.
11. Meydani M. Vitamin E. Lancet 1995, 345(8943):170-175.
12. Gökkusu C., Palanduz S., Ademoĝlu E., Tamer S. Oxidant and antioxidant systems in NIDDM patients: influence of vitamin E supplementation. Endocr Res 2001, 27(3):377-386.
13. Hsu R.M., Devaraj S., Jialal I. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus. Clin Chim Acta 2002, 317(1-2):145-150.
14. Skrha J., Sindelka G., Kvasnicka J., Hilgertová J. Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus. Diabetes Res Clin Pract 1999, 44(1):27-33.
15. Kataja-Tuomola M.K., Kontto J.P., Männistö S., Albanes D., Virtamo J.R. Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study. Ann Med 2010, 42(3):178-186.
16. Pazdro R., Burgess J.R. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev 2010, 131(4):276-286.
17. American Diabetes Association - ADA Report of the Expert Committee on the diagnostics and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
18. Browner W.S., Newman T.B., Hulley S.B. Estimating the sample size and statistical power: applications and examples. Designing clinical research 2007, Lippincott Wilians and Willians/Wolters Kluwer, Philadelphia, USA. 3rd ed. S.B. Hulley, S.R. Cummings, W.S. Browner, D. Grady, N. Hearst, T.B. Newman (Eds.).
19. Clark P., Hales C. Assay of insulin. Textbook of diabetes 1 1991, Blackwell Scientific Publications.
20. Geloneze B., Repetto E.M., Geloneze S.R., Tambascia M.A., Ermetice M.N. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006, 72(2):219-220.
21. Satoh S., Toyo'oka T., Fukushima T., Inagaki S. Simultaneous determination of alpha-lipoic acid and its reduced form by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Anal Technol Biomed Life Sci 2007, 854(1-2):109-115.
22. Lonn E., Yusuf S., Hoogwerf B., Pogue J., Yi Q., Zinman B., et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002, 25:1919-1927.
23. Jacob S., Ruus P., Hermann R., Tritschler H.J., Maerker E., Renn W., et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 1999, 27(3-4):309-314.
24. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Health 2002, 122(1):28-34.
25. Marangon K., Devaraj S., Tirosh O., Packer L., Jialal I. Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med 1999, 27(9-10):1114-1121.
26. Meydani M., Azzi A., Diabetes risk: antioxidants or lifestyle? Am J Clin Nutr 2009, 90:253-254.
27. Devaraj S., Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 2000, 102(2):191-196.
28. Polidori M.C., Mecocci P., Stahl W., Parente B., Cecchetti R., Cherubini A., et al. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev 2000, 16(1):15-19.
29. Sharma A., Kharb S., Chugh S.N., Kakkar R., Singh G.P. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 2000, 49(2):160-162.
30. Rizzo M.R., Abbatecola A.M., Barbieri M., Vietri M.T., Cioffi M., Grella R., et al. Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action. J Am Coll Nutr 2008, 27(4):505-511.
31. Manning P.J., Sutherland W.H., Walker R.J., Williams S.M., De Jong S.A., Ryalls A.R., et al. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 2004, 27(9):2166-2171.
32. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998, 97(11):1029-1036.
33. Brunzell J.D., Ayyobi A.F. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 2003, 115(Suppl. 8A):24S-28S.
34. Kuusisto J., Lempiäinen P., Mykkänen L., Laakso M. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care 2001, 24(9):1629-1633.
35. Tangvarasittichai S., Poonsub P., Tangvarasittichai O. Association of serum lipoprotein ratios with insulin resistance in type 2 diabetes mellitus. Indian J Med Res 2010, 131:641-648.
36. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46(6):733-749.
37. Bonora E., Formentini G., Calcaterra F., Lombardi S., Marini F., Zenari L., et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002, 25(7):1135-1141.
38. Füllert S., Schneider F., Haak E., Rau H., Badenhoop K., Lübben G., et al. Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 2002, 87(12):5503-5506.
39. Kulkamp I.C., Paese K., Guterres S.S., Pohlmann A.R. Stabilization of lipoic acid by encapsulation in polymeric nanocapsules designed for cutaneous administration. Quím Nova 2009, 32(8):2078-2084.